There is currently no strong evidence that additional immune therapy benefits patients with renal cell carcinoma who were ...

The first patient with small cell lung cancer has been dosed in a phase 1/2 trial investigating first-line iadademstat plus ...

I find strength and hope in the daffodils I grow, helping me face chronic lymphocytic leukemia with renewed determination.

The first patient has received TCMCB07 in a phase 2 trial to prevent weight loss in patients with metastatic colorectal ...

Dr. Zafar Sayed discuss the importance of recognizing Head and Neck Cancer Awareness Month and highlights early symptoms of the disease to be aware of.

An AI model may help identify patients with myelofibrosis at high risk of early death after transplant, according to an expert.

Deferring upfront CNS-directed radiation in EGFR-variant and ALK-positive NSCLC may improve outcomes but raises treatment-related toxicity risks.

Antibody-drug conjugates combined with immunotherapy have redefined the standard of care for advanced bladder cancer, ...

Radiation therapy for gastrointestinal cancers is more precise and easier to tolerate due newer technologies and personalized ...

Dr. Petros Grivas discusses the importance of tailoring treatment decisions in bladder cancer based on data from three ...

I stay in the cancer social media world because it helps me cope, even when friends disappear and I’m left wondering if ...

Patients with gastrointestinal cancer may benefit from multidisciplinary care and open communication with their care team, as ...